Stephen Paul Ewald
About Stephen Paul Ewald
Data last updated:
Stephen Paul Ewald has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Medpace Clinical Research India Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Medpace Clinical Research India Private Limited at ₹19.34 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Medpace Clinical Research India Private Limited U24232MH2007PTC338993 | Director | 16 Nov 2020 | 2007 | ₹19.34 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Stephen Paul Ewald
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Stephen Paul Ewald
Stephen Paul Ewald has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Medpace Clinical Research India Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Medpace Clinical Research India Private Limited at ₹19.34 Cr (FY 2025).
Stephen Paul Ewald is associated with 1 company as Director, including Medpace Clinical Research India Private Limited (₹19.34 Cr).
Stephen Paul Ewald has expertise in General Business.
Stephen Paul Ewald has 5 years in corporate governance.
By reported revenue, the largest current company of Stephen Paul Ewald is Medpace Clinical Research India Private Limited, with revenue of ₹19.34 Cr (FY 2025).
Stephen Paul Ewald currently holds positions at 1 company: Medpace Clinical Research India Private Limited (₹19.34 Cr).